tiprankstipranks
Advertisement
Advertisement

AU:NXN Stock Latest News

Nexsen Strikes Strategic Hong Kong Hospital Deal to Advance Point-of-Care Diagnostics
Company AnnouncementsNexsen Strikes Strategic Hong Kong Hospital Deal to Advance Point-of-Care Diagnostics
9d ago
NXN
Nexsen Advances U.S. FDA Pathway and Global Rollout for StrepSure Rapid GBS Test
PremiumCompany Announcements
Nexsen Advances U.S. FDA Pathway and Global Rollout for StrepSure Rapid GBS Test
24d ago
NXN
Nexsen Wins HK$6m Grant to Build Hong Kong Hub for Asia-Pacific StrepSure Rollout
PremiumCompany Announcements
Nexsen Wins HK$6m Grant to Build Hong Kong Hub for Asia-Pacific StrepSure Rollout
2M ago
NXN
Nexsen maps global rollout for rapid GBS test StrepSure
PremiumCompany Announcements
Nexsen maps global rollout for rapid GBS test StrepSure
2M ago
NXN
Nexsen posts wider half-year loss as it accelerates rapid diagnostics pipeline
PremiumCompany Announcements
Nexsen posts wider half-year loss as it accelerates rapid diagnostics pipeline
3M ago
NXN
Nexsen showcases StrepSure GBS diagnostic at global ISSAD 2026 forum
PremiumCompany AnnouncementsNexsen showcases StrepSure GBS diagnostic at global ISSAD 2026 forum
3M ago
NXN
Nexsen Seeks ASX Quotation for 14.2 Million Additional Shares
Premium
Company Announcements
Nexsen Seeks ASX Quotation for 14.2 Million Additional Shares
3M ago
NXN
Nexsen Advances FDA Pathway and Global Expansion for Rapid Point-of-Care Diagnostics
Premium
Company Announcements
Nexsen Advances FDA Pathway and Global Expansion for Rapid Point-of-Care Diagnostics
4M ago
NXN
Nexsen Expands GBS Diagnostic Platform into Neonatal Care with AEA-Funded Project
PremiumCompany Announcements
Nexsen Expands GBS Diagnostic Platform into Neonatal Care with AEA-Funded Project
4M ago
NXN
Nexsen to Release 20.2 Million Escrowed Shares to ASX in February
PremiumCompany Announcements
Nexsen to Release 20.2 Million Escrowed Shares to ASX in February
4M ago
NXN
Nexsen Accelerates US Entry for Rapid GBS Test with FDA Pre-Submission and Leadership Boost
PremiumCompany Announcements
Nexsen Accelerates US Entry for Rapid GBS Test with FDA Pre-Submission and Leadership Boost
5M ago
NXN
Nexsen Limited Engages International Investors with UK Roadshow
PremiumCompany Announcements
Nexsen Limited Engages International Investors with UK Roadshow
5M ago
NXN
Nexsen Limited Appoints Renowned Surgeon-Scientist to Board
PremiumCompany AnnouncementsNexsen Limited Appoints Renowned Surgeon-Scientist to Board
6M ago
NXN
Nexsen Limited Strengthens Board with Appointment of Renowned Clinical Leader
Premium
Company Announcements
Nexsen Limited Strengthens Board with Appointment of Renowned Clinical Leader
6M ago
NXN
Nexsen Limited Successfully Concludes 2025 Annual General Meeting
Premium
Company Announcements
Nexsen Limited Successfully Concludes 2025 Annual General Meeting
6M ago
NXN
Nexsen Limited Accelerates US Market Entry with MCRA Appointment
PremiumCompany Announcements
Nexsen Limited Accelerates US Market Entry with MCRA Appointment
7M ago
NXN
Nexsen Limited’s ASX Debut and Diagnostic Innovations Propel Growth
PremiumCompany Announcements
Nexsen Limited’s ASX Debut and Diagnostic Innovations Propel Growth
7M ago
NXN
Nexsen Limited Announces 2025 Annual General Meeting Details
PremiumCompany Announcements
Nexsen Limited Announces 2025 Annual General Meeting Details
7M ago
NXN
Nexsen Limited Launches Clinical Trial for Innovative Maternal Diagnostic Tool
PremiumCompany Announcements
Nexsen Limited Launches Clinical Trial for Innovative Maternal Diagnostic Tool
7M ago
NXN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >